Cite

    Hochberg, M. et al. (n.d.). AB0552 Relative efficacy and tolerability of intravenous and subcutaneous abatacept compared with tumor necrosis factor inhibitors in rheumatoid arthritis patients with an inadequate response to conventional disease-modifying antirheumatic drugs. Annals of the rheumatic diseases. p. 670. [Online].